Epidemiology, clinical characteristics and potential mechanism of ibrutinib-induced ventricular arrhythmias

• Main Authors: Yilin Pan (Author), Yanan Zhao (Author), Hangyu Ren (Author), Xintong Wang (Author), Caixia Liu (Author), Beibei Du (Author), Kumaraswamy Nanthakumar (Author), Ping Yang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The Bruton's Tyrosine Kinase Inhibitor, ibrutinib, has been widely employed due to its significant efficacy in B-cell lymphoma. However, the subsequent cardiac complications, notably atrial fibrillation (AF) and ventricular arrhythmias (VAs),associated with ibrutinib treatment have emerged as a...